BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• FDA

  Regeneron Receives Six Months of U.S. Pediatric Exclusivity for EYLEA® (aflibercept) Injection

  Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the U.S. Food and Drug Administration (FDA) has granted pediatric exclusivity for EYLEA ® (aflibercept) Injection.

  October 21, 2022

   · 

  11 min read
• Genetown

  Mevion Introduces New MEVION S250-FIT Proton Therapy System

  This new compact system can fit in existing LINAC vaults, making proton therapy more accessible and affordable than ever before.

  October 21, 2022

   · 

  4 min read
• Pharm Country

  U.S. Food and Drug Administration (FDA) Accepts Supplemental New Drug Application for CAMZYOS® (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy to Reduce the Need for Septal Reduction Therapy

  U.S. Food and Drug Administration (FDA) Accepts Supplemental New Drug Application for CAMZYOS ® (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy to Reduce the Need for Septal Reduction Therapy.

  October 21, 2022

   · 

  16 min read
• Lone Star Bio

  Lantern Pharma to Present at the ThinkEquity Conference on Wednesday, October 26 at 1:00 p.m. ET

  Lantern Pharma Inc. today announced that Lantern management will be presenting at the ThinkEquity Conference, which is being held on October 26th , 2022 in New York, NY.

  October 21, 2022

   · 

  4 min read